Lipocine | 10-Q: Quarterly report
Lipocine | 8-K: Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024
Lipocine | 8-K: Current report
Lipocine | 8-K: Current report
Lipocine | 8-K: Current report
Lipocine | 8-K: Current report
Lipocine | 424B5: Prospectus
Lipocine | EFFECT: Others
Lipocine | CORRESP: CORRESP
Lipocine | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Lipocine | DEF 14A: Definitive information statements
Lipocine | 8-K: Current report
Lipocine | 8-K: Current report
Lipocine | 8-K: Current report
Lipocine | 4: Statement of changes in beneficial ownership of securities-Officer Patel Mahesh V.
Lipocine | 4: Statement of changes in beneficial ownership of securities-Officer Fogarty Krista
Lipocine | 8-K: Current report
Lipocine | 8-K: Current report
Lipocine | 10-K: Annual report
Lipocine | 8-K: Current report
No Data